UMC Utrecht study uncovers 29 novel antibodies against Klebsiella pneumoniae

Research at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections.

Membership Medicine: The Future of Primary Care?

Alfredo Fernandez-Concha, EVP of Partnership Strategy Growth at Castle Connolly Todd Bellemare, Sr. VP, Strategic Solutions at Definitive Healthcare Primary care is at a tipping

August 28, 2023

New Monoclonal Authorized to Prevent COVID in Immunocompromised People

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient

March 23, 2024

FDA finds ‘potential systemic bias’ in Amgen’s KRAS drug trial ahead of advisory meeting

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.